Rydén, L <br/><br/>
Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods.  [electronic resource] 

 -  Cardiovascular research  Jan 1975 
 - 81-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0008-6363 
<br/><br/><label>Standard No.: </label>10.1093/cvr/9.1.81  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Arrhythmia Agents--pharmacology<br/>Arrhythmias, Cardiac--drug therapy<br/>Blood Pressure--drug effects<br/>Bundle of His--drug effects<br/>Carbamates--pharmacology<br/>Cardiac Catheterization<br/>Clinical Trials as Topic<br/>Electrocardiography<br/>Electrodes<br/>Electrophysiology<br/>Female<br/>Heart Atria--drug effects<br/>Heart Conduction System--drug effects<br/>Heart Diseases--drug therapy<br/>Heart Rate--drug effects<br/>Heart Ventricles--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Neural Conduction--drug effects<br/>Pacemaker, Artificial<br/>Paresthesia--chemically induced<br/>Quaternary Ammonium Compounds--adverse effects<br/>Refractory Period, Electrophysiological--drug effects<br/>Sinoatrial Node--drug effects